Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon.
about
Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cellsAmphiregulin: a bifunctional growth-modulating glycoprotein produced by the phorbol 12-myristate 13-acetate-treated human breast adenocarcinoma cell line MCF-7Dengue virus-specific cross-reactive CD8+ human cytotoxic T lymphocytesMechanism of anaemia in rheumatoid arthritis: demonstration of raised interleukin 1 beta concentrations in anaemic patients and of interleukin 1 mediated suppression of normal erythropoiesis and proliferation of human erythroleukaemia (HEL) cells inIdentification and characterization of a membrane-bound cytotoxin of murine cytolytic lymphocytes that is related to tumor necrosis factor/cachectinInvolvement of cyclic adenosine monophosphate in the interleukin 4 inhibitory effect on interleukin 2-induced lymphokine-activated killer generation.Inhibition of pluripotent hematopoietic stem cells of bone marrow by large granular lymphocytes.Niche heterogeneity in the bone marrowSecretory products of macrophages.Cell-mediated effector molecules and complicated malaria.Activation of mouse peritoneal macrophages by monoclonal antibodies to Mac-1 (complement receptor type 3)Adult-onset cyclic neutropenia is a benign neoplasm associated with clonal proliferation of large granular lymphocytes.Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells.Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation.Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody.Toxicity and therapeutic efficacy of high-dose interleukin 2. In vivo infusion of antibody to NK-1.1 attenuates toxicity without compromising efficacy against murine leukemiaProduction of hematopoietic colony-stimulating factors by human natural killer cells.Constitutive activity of the tumor necrosis factor promoter is canceled by the 3' untranslated region in nonmacrophage cell lines; a trans-dominant factor overcomes this suppressive effect.Interleukin-12: a master regulator.Early activation of splenic macrophages by tumor necrosis factor alpha is important in determining the outcome of experimental histoplasmosis in mice.TNF-α, a good or bad factor in hematological diseases?Observations on the haemopoietic response to critical illness.Cytokines and effector T cell subsets causing autoimmune CNS disease.A proinflammatory mediator with potential relevance in aging.CD3(+) and/or CD14(+) depletion from cord blood mononuclear cells before ex vivo expansion culture improves total nucleated cell and CD34(+) cell yields.Anaemia in rheumatoid arthritis: role of cytokines.Colony-stimulating factors in the pathogenesis and treatment of disease.Perforin-dependent and -independent pathways of cytotoxicity mediated by lymphocytes.Enhancement of lipopolysaccharide-induced tumor necrosis factor production in mice by carrageenan pretreatment.Tumor necrosis factor-alpha inhibits stem cell factor-induced proliferation of human bone marrow progenitor cells in vitro. Role of p55 and p75 tumor necrosis factor receptors.Cytotoxic cells in immunodeficient athymic mice.Effects of recombinant tumor necrosis factor on proliferation and differentiation of leukemic and normal hemopoietic cells in vitro. Relationship to cell surface receptor.Tumor necrosis factor-alpha alters the metabolism of endothelial cell proteoglycans.Transforming growth factor beta-1 (TGF-beta 1) released by an Epstein-Barr virus (EBV) positive spontaneous lymphoblastoid cell line from a patient with Kostmann's congenital neutropenia inhibits the growth of normal committed haemopoietic progenitoRegulation of hematopoiesis in vitro by alloreactive natural killer cell clones.Suppression of target cell proliferation by natural killer cells.Tumor necrosis factor and lymphotoxin induce differentiation of human myeloid cell lines in synergy with immune interferon.Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes.Gamma interferon and lymphotoxin, released by activated T cells, synergize to inhibit granulocyte/monocyte colony formation.Cytotoxin from polymorphonuclear leukocytes and inflammatory ascitic fluids.
P2860
Q24627585-8636A6C1-25BD-4FA4-8223-344EA48A685DQ24649798-BDB3B54E-A44C-4051-93F7-668691419D0BQ27486631-7E36A778-23A2-4FB7-B549-C47A55D68BCAQ33561273-7671F4BC-6959-491E-AAE4-64C8C199C60BQ33853958-2588410C-BC5B-4C49-B2F0-2925CF5BEE3FQ34253470-CC6C6D58-E006-49D8-AD4B-09EF7F872051Q34360557-FBB0D623-706F-4EA9-8B21-8F033DC9A5F7Q34519860-97C16832-8FC0-4255-883F-0103FBEA7910Q34557411-5AD4B598-5D0A-4565-9DB9-19E3BEA22BAFQ36170491-12903D10-0DAD-49F4-9599-ED9C35FA478CQ36352448-FA8A4347-B09F-4A3F-8A12-7CD2CB71BCEBQ36353212-15A0D2D7-54A5-456F-B0A2-635EB56DF11DQ36354528-5DC2E16C-BD22-4D10-8A86-B71CD246A4D0Q36354640-5D14CFB8-5259-4BD1-859E-9BBB50271F65Q36354676-A5ECD3E5-0D53-4196-B60C-24B711253697Q36355851-B5971814-B792-4AC2-B820-85907AAD1556Q36355949-27AAC53A-CFEB-469A-8D3A-1A70EB107243Q36793833-F24109FB-7C98-4EDC-AF50-59DA66F77CC1Q36814123-EB8AF17B-4CEA-495E-990F-6197C2CC095EQ36951979-29EE27DF-3244-4EBA-8A15-AC034B23C6DAQ37043776-734ED792-5CDB-4DE4-81BA-EDE9A4C1CB71Q37266164-04092D5E-B2D9-4228-AFE1-08457389A8D2Q37863274-CBC571E0-0101-44D7-A968-744782D2F641Q37962343-60D4325A-51B5-4A57-AB1F-3FBB663EBF0CQ38552467-FFCE515A-354C-4452-AF6F-ADEA828C7DB7Q38616102-8D67B7FC-23D3-4FD3-AA96-07A5902033A1Q39177018-9F8C44F9-D4EF-46CE-A1F5-A742CF56C313Q39651613-1CEAC7FB-4C48-46E5-9466-97E705C71867Q40150008-50F19602-5C8B-4B4E-968A-CE28CF0A85EAQ40345734-F2A8B16D-20D8-4994-8FF0-1D260F4BE0A5Q40395786-3C35B8DE-0CAE-48DD-8E58-83A31488CC56Q40920137-89C6631D-DA77-4CDD-8BEE-3477491F73CAQ41503913-D8CEEEAC-6C5A-4045-88CF-429051D9A0D0Q41512659-A829C2E9-E5B5-45B7-9C58-A0B34F088DE2Q41562390-E9BBCCE9-216F-4370-9368-B5016C89DBD5Q41715514-EB1AA160-2D64-44B0-8276-438884E46273Q41809956-7AB711B4-0D8C-4066-B467-7A79D12C411EQ41845609-20327300-B3A7-4132-A33B-8FD10DBCD55AQ41921376-C3A82F5B-BCDF-4DD4-B1E1-386E4EB5D2A5Q42065132-150AA3DC-473A-4848-B84B-1B7BB10C2BF1
P2860
Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
Natural killer (NK) cell-deriv ...... ergism with immune interferon.
@ast
Natural killer (NK) cell-deriv ...... ergism with immune interferon.
@en
type
label
Natural killer (NK) cell-deriv ...... ergism with immune interferon.
@ast
Natural killer (NK) cell-deriv ...... ergism with immune interferon.
@en
prefLabel
Natural killer (NK) cell-deriv ...... ergism with immune interferon.
@ast
Natural killer (NK) cell-deriv ...... ergism with immune interferon.
@en
P2093
P2860
P356
P1476
Natural killer (NK) cell-deriv ...... ergism with immune interferon.
@en
P2093
B Perussia
G Degliantoni
G Trinchieri
M K Francis
M Kobayashi
P2860
P304
P356
10.1084/JEM.162.5.1512
P407
P577
1985-11-01T00:00:00Z